Coronary artery disease patients no longer must go through invasive procedures to get their fractional flow reserve (FFR) measured. The computation of FFR can now be done in a non-invasive way invented by HeartFlow, a new company once incubated at Fogarty Institute of Innovation. Founded within El Camino Hospital in 2007, Forgarty Institute provides intellectual, physical, and financial resources for medical technology start-ups in residence. So far three companies have "graduated" from the institute. Besides HeartFlow, PQ Bypass offers a non-surgical, long-lasting bypass in the femoral artery; Niveus has launched a device to preserve muscle mass and strength in intensive care unit patients.
Read the entire article on the Cupertino Patch website.